IL-19 is reported to directly affect breast cancer cell proliferation, migration, and tumor progression by inducing the expression of cytokines and chemokines while the expression levels are connected to advanced stages, higher mitotic rates, and metastasis. Here, IL19 is linked to breast carcinoma.